Scopia Management, Inc., 10% Owner at ACORDA THERAPEUTICS INC (ACOR), bought 882,402 shares at $19.05 ($17.0M) on 2017-08-29, disclosed to the SEC on 2017-08-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.05 | 500,000 | $9.5M | 56.0% |
| 2 | $19.52 | 150,000 | $2.9M | 17.2% |
| 3 | $19.62 | 116,201 | $2.3M | 13.4% |
| 4 | $19.62 | 116,201 | $2.3M | 13.4% |
| Total | $19.28 avg | 882,402 | $17.0M | 100% |
| Filing → |
| ITRI | SELL | 2019-04-16 | $5.9M | — | Filing → |
| ITRI | SELL | 2019-03-29 | $3.0M | — | Filing → |
| ITRI | SELL | 2019-03-25 | $5.8M | — | Filing → |